Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar
Open accessPublished version of a preprint
Abstract
ABSTRACT Background Qatar experienced a large severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual workers (CMWs) who constitute 60% of the population. This study aimed to investigate level of immunity in communities within this population as well as infection exposure required to achieve herd immunity. Methods Anti - SARS-CoV-2 seropositivity was assessed in ten CMW communities between June 21 and September 9, 2020. PCR positivity, infection positivity (antibody and/or PCR positive), and infection severity rate were also estimated. Associations with anti-SARS-CoV-2 positivity were investigated using regression analyses. Results Study included 4,970 CMWs who were mostly men (95.0%) and <40 years of age (71.5%). Seropositivity ranged from 54.9% (95% CI: 50.2-59.4%) to 83.8% (95% CI: 79.1-87.7%) in the different CMW communities. Pooled mean seropositivity across all communities was 66.1% (95% CI: 61.5-70.6%). PCR positivity ranged from 0.0% to 10.5% (95% CI: 7.4-14.8%) in the different CMW communities. Pooled mean PCR positivity was 3.9% (95% CI: 1.6-6.9%). Median cycle threshold (Ct) value was 34.0 (range: 15.8-37.4)—majority (79.5%) of PCR-positive individuals had Ct value >30 indicative of earlier rather than recent infection. Infection positivity (antibody and/or PCR positive) ranged from 62.5% (95% CI: 58.3-66.7%) to 83.8% (95% CI: 79.1-87.7%) in the different CMW communities. Pooled mean infection positivity was 69.5% (95% CI: 62.8-75.9%). Only five infections were ever severe and one was ever critical—an infection severity rate of 0.2% (95% CI: 0.1-0.4%). Conclusions Based on an extended range of epidemiological measures, active infection is rare in these communities with limited if any sustainable infection transmission for clusters to occur. At least some CMW communities in Qatar have reached or nearly reached herd immunity for SARS-CoV-2 infection at a proportion of ever infection of 65-70%.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cases and controls were exact-matched by sex, 10-year-age group, nationality, and calendar week of PCR test to control for established differences in risk of exposure to SARS-CoV-2 infection in Qatar.
“Cases (persons infected with BA.1, BA.2, or any-Omicron-subvariant) and controls (uninfected persons) were exact-matched by sex, 10-year-age group, nationality, and calendar week of polymerase chain reaction (PCR) test to control for established differences in the risk of exposure to SARS-CoV-2 infection in Qatar15–19.”
From Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar (2022) · cites this paper as [19]
Earlier seroprevalence studies conducted in the same population have shown that a considerable proportion of SARS-CoV-2 infections went undocumented.
“Earlier seroprevalence studies conducted in the same population have shown that a considerable proportion of infections went undocumented17–19.”
From Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar (2022) · cites this paper as [19]
Matching was implemented to control for established differences in the risk of exposure to SARS-CoV-2 infection in Qatar.
“Matching was implemented to control for established differences in the risk of exposure to SARS-CoV-2 infection in Qatar15–19.”
From Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · see citing works
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648 · see citing works
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · see citing works
Prevalence of Asymptomatic SARS-CoV-2 Infection
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,280 · see citing works
Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169 · see citing works
Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Fernández de Larrea, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31483-5 · Cited by 1,639 · see citing works
Interpreting Diagnostic Tests for SARS-CoV-2.
Sethuraman, N., Jeremiah, S. S., & Ryo, A. (2020) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2020.8259 · Cited by 1,420 · see citing works
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195 · see citing works
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940 · see citing works
Infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J. P. A. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265892 · Cited by 684 · see citing works
Britton, T., Ball, F., & Trapman, P. (2020) · Science · doi:10.1126/science.abc6810 · Cited by 645 · see citing works
The Inverse of the Freeman – Tukey Double Arcsine Transformation
Miller, J. J. (1978) · The American Statistician · doi:10.1080/00031305.1978.10479283 · Cited by 501 · see citing works
Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity
Cheng, K. K., Lam, T. H., & Leung, C. C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30918-1 · Cited by 454 · see citing works
Kubina, R., & Dziedzic, A. M. (2020) · Diagnostics · doi:10.3390/diagnostics10060434 · Cited by 252 · see citing works
Koh, D. (2020) · Occupational and Environmental Medicine · doi:10.1136/oemed-2020-106626 · Cited by 232 · see citing works
The infection fatality rate of COVID-19 inferred from seroprevalence dataPreprint
Ioannidis, J. P. A. (2020) · medRxiv · doi:10.1101/2020.05.13.20101253 · Cited by 227 · see citing works
School closures and influenza: systematic review of epidemiological studies
Jackson, C., Vynnycky, E., Hawker, J., Olowokure, B., & Mangtani, P. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002149 · Cited by 224 · see citing works
Wajnberg, A., Mansour, M., Leven, E. A., Bouvier, N. M., Patel, G., Firpo‐Betancourt, A., Mendu, R., Jhang, J. S., Arinsburg, S. A., Gitman, M., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30120-8 · Cited by 222 · see citing works
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible
Nikolai, L. A., Meyer, C. G., Kremsner, P. G., & Velavan, T. P. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.076 · Cited by 220 · see citing works
He, W., Yi, G. Y., & Zhu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26041 · Cited by 187 · see citing works
Abu-Raddad, L. J., Chemaitelly, H. S., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Kanaani, Z. A., Al‐Khal, A., Al‐Kuwari, E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1846 · Cited by 176 · see citing works
Self-citationMuench, P., Jochum, S., Wenderoth, V., Ofenloch-Haehnle, B., Hombach, M., Strobl, M., Sadlowski, H., Sachse, C., Torriani, G., Eckerle, I., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01694-20 · Cited by 165 · see citing works
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85428-7 · Cited by 148 · see citing works
Self-citationOved, K., Olmer, L., Shemer-Avni, Y., Wolf, T., Supino-Rosin, L., Prajgrod, G., Shenhar, Y., Payorsky, I., Cohen, Y., Kohn, Y., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100651 · Cited by 129 · see citing works
Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
Makhoul, M., Ayoub, H. H., Chemaitelly, H., Seedat, S., Mumtaz, G. R., Al-Omari, S., & Abu-Raddad, L. J. (2020) · Vaccines · doi:10.3390/vaccines8040668 · Cited by 107 · see citing works
Self-citationHerd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemicsPreprint
Aguas, R. J., Gonçalves, G., Ferreira, M. U., & Gomes, M. G. M. (2020) · medRxiv · doi:10.1101/2020.07.23.20160762 · Cited by 93 · see citing works
Demography, migration, and labour market in Qatar
Bel-Air, F. D. (2014) · Cadmus - EUI Research Repository (European University Institute) · Cited by 87 · see citing works
Ayoub, H. H., Chemaitelly, H., Seedat, S., Makhoul, M., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05005 · Cited by 81 · see citing works
Self-citationKuwari, H. M. A., Rahim, H. A. A., Abu-Raddad, L., Abou-Samra, A., Al-Kanaani, Z., Khal, A. A., Al-Kuwari, E., Marri, S. A., Masalmani, M. A., Al-Romaihi, H., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040428 · Cited by 81 · see citing works
Self-citationGlatman‐Freedman, A., Portelli, I., Jacobs, S. K., Mathew, J. I., Slutzman, J. E., Goldfrank, L. R., & Smith, S. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050228 · Cited by 62 · see citing works
Guijarro, C., Pérez‐Fernández, E., González-Piñeiro, B., Meléndez, V., Goyanes, M. J., Renilla, M. E., Casas, M. L. M. D. L., Sastre, I., & Velasco, M. (2021) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2020.10.005 · Cited by 35 · see citing works
Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China
Makhoul, M., Chemaitelly, H. S., Ayoub, H. H., Seedat, S., & Abu-Raddad, L. J. (2021) · Vaccines · doi:10.3390/vaccines9030223 · Cited by 29 · see citing works
Self-citationKalikiri, M. K. R., Hasan, M. R., Mirza, F., Xaba, T., Tang, P., & Lorenz, S. (2020) · medRxiv · doi:10.1101/2020.04.08.20055731 · Cited by 28 · see citing works
Bagdasarian, N., & Fisher, D. A. (2020) · BMC Medicine · doi:10.1186/s12916-020-01625-7 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Chemaitelly, H., Tang, P., Hasan, M. R., AlMukdad, S., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Coyle, P., Ayoub, H. H., Al Kanaani, Z., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114114 · Cited by 831 · see citing works
Self-citationEffects of Previous Infection and Vaccination on Symptomatic Omicron Infections
Altarawneh, H. N., Chemaitelly, H., Ayoub, H. H., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Coyle, P., Al-Kanaani, Z., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203965 · Cited by 551 · see citing works
Self-citationBNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
Tang, P., Hasan, M. R., Chemaitelly, H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., AlMukdad, S., Coyle, P., Ayoub, H. H., Al Kanaani, Z., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01583-4 · Cited by 450 · see citing works
Self-citationProtection against the Omicron Variant from Previous SARS-CoV-2 Infection
Altarawneh, H. N., Chemaitelly, H., Hasan, M. R., Ayoub, H. H., Qassim, S., AlMukdad, S., Coyle, P., Yassine, H. M., Al-Khatib, H. A., Benslimane, F. M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2200133 · Cited by 445 · see citing works
Self-citationChemaitelly, H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., Hasan, M. R., Malek, J. A., Coyle, P., Ayoub, H. H., Al Kanaani, Z., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01446-y · Cited by 386 · see citing works
Self-citationEffect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Tang, P., Hasan, M. R., Coyle, P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200797 · Cited by 380 · see citing works
Self-citationDuration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30895-3 · Cited by 228 · see citing works
Self-citation(2021) · doi:10.1016/j.eclinm.2021.100861 · Cited by 201 · see citing works
Self-citationAbu-Raddad, L. J., Chemaitelly, H. S., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Kanaani, Z. A., Al‐Khal, A., Al‐Kuwari, E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1846 · Cited by 176 · see citing works
Self-citationAbu-Raddad, L. J., Chemaitelly, H. S., Ayoub, H. H., Yassine, H. M., Benslimane, F. M., Al-Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P. V., Kanaani, Z. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.19623 · Cited by 165 · see citing works
Self-citationCOVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar
Saththasivam, J., El-Malah, S. S., Gomez, T., Jabbar, K. A., Remanan, R., Krishnankutty, A. K., Ogunbiyi, O. O., Rasool, K., Ashhab, S., Rashkeev, S. N., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145608 · Cited by 150 · see citing works
Self-citationProtective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
Altarawneh, H. N., Chemaitelly, H. S., Ayoub, H. H., Hasan, M. R., Coyle, P. V., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2209306 · Cited by 144 · see citing works
Self-citationCharacterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85428-7 · Cited by 148 · see citing works
Self-citationDuration of immune protection of SARS-CoV-2 natural infection against reinfection
Chemaitelly, H. S., Nagelkerke, N. J. D., Ayoub, H. H., Coyle, P. V., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Kanaani, Z. A., et al. (2022) · Journal of Travel Medicine · doi:10.1093/jtm/taac109 · Cited by 107 · see citing works
Self-citationOver- and under-estimation of COVID-19 deaths
Ioannidis, J. P. A. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00787-9 · Cited by 104 · see citing works
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
Al-Thani, M. H., Farag, E., Bertollini, R., Al Romaihi, H. E., Abdeen, S., Abdelkarim, A., Daraan, F., Elhaj Ismail, A. I. H., Mostafa, N., Sahl, M., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab221 · Cited by 85 · see citing works
Self-citationCoyle, P. V., Chemaitelly, H., Ben Hadj Kacem, M. A., Abdulla Al Molawi, N. H., El Kahlout, R. A., Gilliani, I., Younes, N., Al Anssari, G. A. A. A., Al Kanaani, Z., Al Khal, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102646 · Cited by 86 · see citing works
Self-citationProtection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
(2022) · doi:10.1038/s41467-022-32363-4 · Cited by 84 · see citing works
Self-citationAbu-Raddad, L. J., Chemaitelly, H. S., Ayoub, H. H., Tang, P., Coyle, P. V., Hasan, M. R., Yassine, H. M., Benslimane, F. M., Al-Khatib, H. A., Kanaani, Z. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28199-7 · Cited by 79 · see citing works
Self-citationImmune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
Chemaitelly, H. S., Ayoub, H. H., Tang, P., Hasan, M. R., Coyle, P. V., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2211055 · Cited by 74 · see citing works
Self-citationAyoub, H. H., Chemaitelly, H., Seedat, S., Makhoul, M., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05005 · Cited by 81 · see citing works
Self-citationEffectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
Abu-Raddad, L. J., Chemaitelly, H., & Bertollini, R. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2117933 · Cited by 79 · see citing works
Self-citationChemaitelly, H., Ayoub, H. H., AlMukdad, S., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00287-7 · Cited by 76 · see citing works
Self-citationCovid-19 Vaccine Protection among Children and Adolescents in Qatar
Chemaitelly, H. S., AlMukdad, S., Ayoub, H. H., Altarawneh, H. N., Coyle, P. V., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2210058 · Cited by 71 · see citing works
Self-citationHasan, M. R., Kalikiri, M. K. R., Mirza, F., Sundararaju, S., Sharma, A., Xaba, T., Lorenz, S., Chemaitelly, H. S., Kahlout, R. A. E., Tsui, C. K. M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.006 · Cited by 65 · see citing works
Self-citationSARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
Seedat, S., Chemaitelly, H., Ayoub, H. H., Makhoul, M., Mumtaz, G. R., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97606-8 · Cited by 63 · see citing works
Self-citationDifferential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · Nature · doi:10.1038/s41586-024-08511-9 · Cited by 59 · see citing works
Self-citationAbu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Coyle, P., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Tang, P., Al Kanaani, Z., et al. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003879 · Cited by 54 · see citing works
Self-citationAltarawneh, H. N., Chemaitelly, H. S., Ayoub, H. H., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Thani, A. A. A., Coyle, P. V., Kanaani, Z. A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104734 · Cited by 55 · see citing works
Self-citationAyoub, H. H., Mumtaz, G. R., Seedat, S., Makhoul, M., Chemaitelly, H. S., & Abu-Raddad, L. J. (2021) · Global Epidemiology · doi:10.1016/j.gloepi.2021.100068 · Cited by 47 · see citing works
Self-citationQassim, S. H., Chemaitelly, H. S., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Rahim, H. F. A., et al. (2022) · Journal of Travel Medicine · doi:10.1093/jtm/taac068 · Cited by 47 · see citing works
Self-citationTayar, E., Abdeen, S., Alah, M. A., Chemaitelly, H. S., Bougmiza, I. M., Ayoub, H. H., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Al‐Romaihi, H. E., et al. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.12.016 · Cited by 44 · see citing works
Self-citationAll-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
Al-Nuaimi, A. A., Chemaitelly, H. S., Semaan, S., AlMukdad, S., Kanaani, Z. A., Kaleeckal, A. H., Latif, A. N., Al‐Romaihi, H. E., Butt, A. A., Al‐Thani, M. H., et al. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012291 · Cited by 42 · see citing works
Self-citationAyoub, H. H., Tomy, M., Chemaitelly, H. S., Altarawneh, H. N., Coyle, P. V., Tang, P., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., et al. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad239 · Cited by 40 · see citing works
Self-citationChemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., Yassine, H. M., Khatib, H. A. A., Smatti, M. K., Coyle, P., Kanaani, Z. A., et al. (2022) · doi:10.1101/2022.02.07.22270568 · Cited by 30 · see citing works
Self-citationChemaitelly, H. S., Faust, J. S., Krumholz, H. M., Ayoub, H. H., Tang, P., Coyle, P. V., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.09.005 · Cited by 38 · see citing works
Self-citationQassim, S. H., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., Kanaani, Z. A., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102102 · Cited by 32 · see citing works
Self-citationSARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
Popova, A. Y., Смирнов, В. С., Andreeva, E. E., Babura, E. A., Балахонов, С. В., Bashketova, N. S., Александровна, Б. С., Bulanov, M. V., Valeullina, N. N., Ветров, В. В., et al. (2021) · Viruses · doi:10.3390/v13081648 · Cited by 30 · see citing works
Ayoub, H. H., Chemaitelly, H. S., Makhoul, M., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., Coyle, P. V., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., et al. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2021-000677 · Cited by 30 · see citing works
Self-citationNasrallah, G. K., Dargham, S. R., Shurrab, F. M., Al‐Sadeq, D. W., Al-Jighefee, H. T., Chemaitelly, H. S., Kanaani, Z. A., Al‐Khal, A., Al‐Kuwari, E., Coyle, P. V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91235-x · Cited by 29 · see citing works
Self-citationEl-Malah, S. S., Saththasivam, J., Jabbar, K. A., Arun, K. K., Gomez, T., Ahmed, A. A., Mohamoud, Y. A., Malek, J. A., Abu-Raddad, L. J., Halaweh, H. A. A., et al. (2022) · Environmental Technology & Innovation · doi:10.1016/j.eti.2022.102775 · Cited by 29 · see citing works
Self-citationAyoub, H. H., Tomy, M., Chemaitelly, H., Altarawneh, H. N., Coyle, P., Tang, P., Hasan, M. R., Kanaani, Z. A., Kuwari, E. A., Butt, A. A., et al. (2022) · doi:10.1101/2022.01.02.22268622 · Cited by 41 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Faust, J. S., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Thani, A. A. A., Kanaani, Z. A., et al. (2023) · BMJ Public Health · doi:10.1136/bmjph-2023-000479 · Cited by 26 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · eLife · doi:10.7554/elife.103690 · Cited by 26 · see citing works
Self-citationAmereh, F., Jahangiri‐rad, M., Mohseni-Bandpei, A., Mohebbi, S. R., Asadzadeh‐Aghdaei, H., Dabiri, H., Eslami, A., Roostaei, K., Aali, R., Hamian, P., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152597 · Cited by 25 · see citing works
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months
Abu-Raddad, L. J., Chemaitelly, H. S., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Kanaani, Z. A., Al‐Khal, A., Al‐Kuwari, E., Butt, A. A., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104684 · Cited by 22 · see citing works
Self-citationProtection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
Chemaitelly, H. S., Coyle, P. V., Kacem, M. A. B. H., Ayoub, H. H., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2024) · Journal of Travel Medicine · doi:10.1093/jtm/taae053 · Cited by 21 · see citing works
Self-citationAl-Abri, S., Wahaibi, A. S. A., Al-Kindi, H., Kurup, P. J., Al-Maqbali, A., Almayahi, Z. K., Al-Tobi, M. H., Al-Katheri, S. H., Albusaidi, S., Al-Sukaiti, M. H., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.062 · Cited by 21 · see citing works
History of primary-series and booster vaccination and protection against Omicron reinfection
Chemaitelly, H. S., Ayoub, H. H., Tang, P., Coyle, P. V., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh0761 · Cited by 30 · see citing works
Self-citationAddressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
Chemaitelly, H. S., Ayoub, H. H., Tang, P., Yassine, H. M., Thani, A. A. A., Hasan, M. R., Coyle, P. V., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1363045 · Cited by 17 · see citing works
Self-citationSukik, L., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Yassine, H. M., Thani, A. A. A., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.04.026 · Cited by 17 · see citing works
Self-citationSARS-CoV-2 infection in mortuary and cemetery workers
Alishaq, M., Jeremijenko, A. M., Nafady‐Hego, H., Ajmi, J. A. A., Elgendy, M., Fadel, R. A. A., Thomas, A. G., Alahmed, M. A. A., Ammar, A. A., Bensaad, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.012 · Cited by 16 · see citing works
Self-citationBsat, R., Chemaitelly, H. S., Coyle, P. V., Tang, P., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., Jeremijenko, A. M., Kaleeckal, A. H., et al. (2022) · Journal of Global Health · doi:10.7189/jogh.12.05004 · Cited by 14 · see citing works
Self-citationCOVID-19 primary series and booster vaccination and potential for immune imprintingPreprint
Chemaitelly, H. S., Ayoub, H. H., Tang, P., Coyle, P. V., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · medRxiv · doi:10.1101/2022.10.31.22281756 · Cited by 14 · see citing works
Self-citationMahmoud, M., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13224 · Cited by 12 · see citing works
Self-citationSARS-CoV-2 vaccine effectiveness in immunosuppressed kidney transplant recipients
Chemaitelly, H., AlMukdad, S., Joy, J. P., Ayoub, H. H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., et al. (2021) · doi:10.1101/2021.08.07.21261578 · Cited by 12 · see citing works
Self-citationSeroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar
Nasrallah, G. K., Dargham, S. R., Al‐Sadeq, D. W., Amanullah, F. H., Shurrab, F. M., Nizamuddin, P. B., Chemaitelly, H. S., Ayoub, H. H., Abdeen, S., Abdelkarim, A., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02157-1 · Cited by 11 · see citing works
Self-citationAlishaq, M., Jeremijenko, A. M., Kanaani, Z. A., Nafady‐Hego, H., Jboor, D. H., Saba, R., Al-Ajmi, J., Alansari, N. A., Thomas, A. G., Fareh, S. B., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257845 · Cited by 11 · see citing works
Self-citationAbu-Raddad, L. J., Dargham, S. R., Chemaitelly, H. S., Coyle, P. V., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271324 · Cited by 11 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13357 · Cited by 8 · see citing works
Self-citationPrevalence of hepatitis B and C viruses among migrant workers in Qatar
Nasrallah, G. K., Chemaitelly, H. S., Ismail, A. I. A., Nizamuddin, P. B., Al‐Sadeq, D. W., Shurrab, F. M., Amanullah, F. H., Al-Hamad, T., Mohammad, K. N., Alabdulmalek, M. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61725-9 · Cited by 8 · see citing works
Self-citationGlobal Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis
Ayoub, H. H., Chemaitelly, H. S., & Abu-Raddad, L. J. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70154 · Cited by 5 · see citing works
Self-citationModeling the population-level impact of treatment on COVID-19 disease and SARS-CoV-2 transmission
Makhoul, M., Abu-Hijleh, F. M., Ayoub, H. H., Seedat, S., Chemaitelly, H. S., & Abu-Raddad, L. J. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100567 · Cited by 5 · see citing works
Self-citationChemaitelly, H. S., Faust, J. S., Krumholz, H. M., Ayoub, H. H., Tang, P., Coyle, P. V., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., et al. (2023) · medRxiv · doi:10.1101/2023.01.29.23285152 · Cited by 5 · see citing works
Self-citationPrevalence of syphilis infection among migrant workers in Qatar: a nationwide cross-sectional survey
Nasrallah, G. K., Chemaitelly, H. S., Ismail, A., Al‐Sadeq, D. W., Amanullah, F. H., Al-Emadi, J. A., Khalid, H. M., Nizamuddin, P. B., Shaar, I. A., Karimeh, I. W., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083810 · Cited by 4 · see citing works
Self-citationAlishaq, M., Jeremijenko, A. M., Nafady‐Hego, H., Ajmi, J. A. A., Elgendy, M., Thomas, A. G., Coyle, P. V., Elgendy, H. M., Abou‐Samra, A., & Butt, A. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-12134-4 · Cited by 4 · see citing works
Self-citationProtection against reinfection with SARS-CoV-2 omicron BA.2.75 * sublineagePreprint
Chemaitelly, H. S., Tang, P., Coyle, P. V., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Ayoub, H. H., Altarawneh, H. N., Kanaani, Z. A., et al. (2022) · medRxiv · doi:10.1101/2022.10.29.22281606 · Cited by 4 · see citing works
Self-citationAltarawneh, H. N., Chemaitelly, H. S., Ayoub, H. H., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Thani, A. A. A., Coyle, P. V., Kanaani, Z. A., et al. (2023) · medRxiv · doi:10.1101/2023.04.21.23288917 · Cited by 4 · see citing works
Self-citationSukik, L., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-19168-3 · Cited by 3 · see citing works
Self-citationImmune histories and natural infection protection during the omicron era
Chemaitelly, H. S., Ayoub, H. H., Bobrovitz, N., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00974-9 · Cited by 3 · see citing works
Self-citationMbarek, H., Cocca, M., Al-Sarraj, Y. A., Saad, C., Mezzavilla, M., Al‐Muftah, W., Cocciadiferro, D., Novelli, A., Quinti, I., Al-Tawashi, A., et al. (2021) · Genes · doi:10.3390/genes12111842 · Cited by 3 · see citing works
Osman, K., Mundodan, J. M., Chowdhury, J., Ravi, R. P., Baaboura, R., Albuquerque, J., Riaz, B., Emran, R. Y., Batoul, K., Esameldin, A. M., et al. (2023) · Vaccines · doi:10.3390/vaccines11101522 · Cited by 2 · see citing works
Chemaitelly, H. S., Ayoub, H. H., Tang, P., Coyle, P. V., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · medRxiv · doi:10.1101/2022.11.14.22282103 · Cited by 3 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127556 · Cited by 2 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11410-7 · Cited by 2 · see citing works
Self-citationSeroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
Alishaq, M., Nafady‐Hego, H., Jeremijenko, A. M., Ajmi, J. A. A., Elgendy, M., Al-Ansari, N. A., Elgendy, H. M., Abou‐Samra, A., & Butt, A. A. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s360241 · Cited by 2 · see citing works
Self-citationPrevalence of hepatitis A virus among migrant workers in Qatar: A national study
Younes, N., Chemaitelly, H. S., Nizamuddin, P. B., Al-Hamad, T., Abdallah, M., Yassine, H. M., Abu-Raddad, L. J., & Nasrallah, G. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306753 · Cited by 2 · see citing works
Self-citationAlishaq, M., Ajmi, J. A. A., Shaheen, M., Elgendy, M., Vinoy, S., Thomas, A. G., Joseph, S., Mathew, T. E., Joseph, R., Thomas, C., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291989 · Cited by 2 · see citing works
Self-citationShaik, A. B., Shaik, N. F., Majid, S. S. A., & Sheik, S. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20205460 · Cited by 2 · see citing works
Coyle, P. V., Kahlout, R. A. E., Dargham, S. R., Chemaitelly, H. S., Kacem, M. A. B. H., Al-Mawlawi, N., Gilliani, I., Younes, N., Kanaani, Z. A., Al‐Khal, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262897 · Cited by 2 · see citing works
Self-citationCategorizing the Status of COVID-19 Outbreaks Around the WorldPreprint
Callan, J. P., Nouwen, C. J. A., Lexmond, A. S., & Fourtassi, O. (2021) · medRxiv · doi:10.1101/2021.03.08.21252586 · Cited by 2 · see citing works
Herd Immunity: Communicating Collective Action to Suppress COVID-19 in Two Nordic Countries
Mello, S. (2024) · Risk, systems and decisions · doi:10.1007/978-3-031-74062-6_26 · Cited by 1 · see citing works
Sukik, L., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-002718 · Cited by 1 · see citing works
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331654 · Cited by 1 · see citing works
Self-citationShah, J. N., Samson, P., Pradhan, N. M. S., Shrestha, A., Maharjan, S., Shrestha, S. D., & Sarala, K. C. (2021) · Journal of Patan Academy of Health Sciences · doi:10.3126/jpahs.v8i2.28833 · Cited by 1 · see citing works
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
Alfouzan, W. A., Altawalah, H., Al-Sarraf, A. J., Alali, W. Q., Al-Fadalah, T., Al-Ghimlas, F., Alajmi, S., Alajmi, M., AlRoomi, E., Jeragh, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11020336 · Cited by 1 · see citing works
Effect of BNT162b2 antigen dosage on protection against SARS-CoV-2 omicron infectionPreprint
Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Yassine, H. M., Thani, A. A. A., Al-Khatib, H. A., Hasan, M. R., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · medRxiv · doi:10.1101/2022.11.29.22282864 · Cited by 1 · see citing works
Self-citationJeremijenko, A. M. (2022) · The APPEA Journal · doi:10.1071/aj21059
Self-citationSaidarakath, J., Gadhavi, B. J., Awad, M. O., AlSaadi, M. M., Kattil, M. C., & Alnuaimi, A. S. (2024) · Cureus · doi:10.7759/cureus.54406
Dawdani, A., Liatsou, I., Giramahoro, M. G., Sypsa, V., Gope, P., Miah, M., Kalamitsis, G., Paraskevis, D. N., Trinitapoli, J. A., Kandula, N. R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4816756
Aishaq, M., Nafady‐Hego, H., Abid, F. B., Ajmi, J. A. A., Hamdi, W. S., Vinoy, S., Thomas, A. G., Alrwashdh, S., Shaheen, M. Z., Mathew, T. E., et al. (2024) · Global Epidemiology · doi:10.1016/j.gloepi.2024.100149
Self-citationAyoub, H. H., Chemaitelly, H. S., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Coyle, P. V., Kanaani, Z. A., Al‐Kuwari, E., Kaleeckal, A. H., et al. (2025) · Public Health · doi:10.1016/j.puhe.2025.106016
Self-citationNasrallah, G. K., Dargham, S. R., Al‐Sadeq, D. W., Amanullah, F. H., Shurrab, F. M., Nizamuddin, P. B., Chemaitelly, H. S., Ayoub, H. H., Abdeen, S., Abdelkarim, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24013017
Self-citationAssessing the Impact of the Healthy Vaccinee Effect on COVID-19 Vaccine Effectiveness EstimatesPreprint
Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2026) · medRxiv · doi:10.64898/2026.01.02.26343330
Self-citationHealthy vaccinee effect did not bias COVID-19 vaccine effectiveness estimates
Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2026) · Communications Health · doi:10.1038/s44528-026-00006-5 · Cited by 1 · see citing works
Self-citationChemaitelly, H. S., Akhtar, N., Jerdi, S. A., Kamran, S., Joseph, S., Morgan, D., Uy, R., Abid, F. B., Al‐Khal, A., Abou‐Samra, A., et al. (2026) · Expert Review of Vaccines · doi:10.1080/14760584.2026.2720953
Self-citationChemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., Jeremijenko, A. M., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag602
Self-citationSukik, L., Paul, P., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2026) · International Journal of Epidemiology · doi:10.1093/ije/dyag210
Self-citation
- Authors
- Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A.-B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Al-Mohammed, A., Al Molawi, N. H. A., Al Naomi, H. M., Butt, A. A., Coyle, P., El Kahlout, R. A., Gillani, I., Kaleeckal, A. H., Masoodi, N. A., Thomas, A. G., Nafady-Hego, H., Latif, A. N., Shaik, R. M., Younes, N. B. M., Rahim, H. F. A., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., & Abu-Raddad, L. J.
- Affiliations
- Cornell University (US)
- Corresponding author
- Jeremijenko, Andrew
- Abu-Raddad, Laith J.
- ORCID
- Venue
- Emerging Infectious Diseases
- Published
- 2021-05
- Volume
- 27
- Issue
- 5
- Pages
- 1343-1352
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC8084480
- OpenAlex
- W3158710728
- Cited by
- 97
- References
- 35
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 26 · 2021: 27 · 2020: 3
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Greater South Information System
- Funders
- Hamad Medical Corporation
- Weill Cornell Medical College
- Weill Cornell Medicine - Qatar
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- herd immunity, SARS-CoV-2, COVID-19 pandemic, community transmission, epidemic peak, epidemic curve, SARS-CoV-2 prevalence, Qatar
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Qatar, Immunity, Herd
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review